Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in C57Bl/6 mice gave maximal and significant luciferase expression in the lungs with the cationic polymer PEI 22K/DNA complexes at the highest ratios of positive/negative charges versus DNA alone. While DOTAP/DNA complexes with high charge ratio determined lower but still significant luciferase activity versus uncomplexed DNA, GL-67A and PEI 25K mediated negligible luciferase expression. Labelled PEI 22K and DOTAP complexes were evenly distributed in the alveolar region, where GFP expression was revealed, while PEI 25K and GL-67A complexes were not detected, suggesting a different interaction of these complexes with the plasma membrane of endothelial cells. Following an intratracheal injection, the highest and significant levels of transfection were obtained with
Introduction
Gene delivery to the airway epithelium is a major goal for lung gene therapy, but success depends on overcoming the biological and physicochemical barriers which the vector encounters in the tracheo-bronchial tree. This concept has been highlighted when demonstration of limited efficient gene transfer was obtained in human airways, as in the case of cystic fibrosis (CF) patients with both nonviral and viral vectors. [1] [2] [3] [4] Considering only nonviral DNA delivering agents, several previous works have achieved gene transfer with cationic lipids (lipofection) and polymers (polyfection) to the lungs of laboratory animals by either direct instillation in the nose and trachea [5] [6] [7] or via the aerosol administration. 8, 9 Systemic intravenous infusion of cationic vector/DNA complexes has been attempted and shown to transfect preferentially the lung tissue. 7, [10] [11] [12] [13] The most important determinants for cationic lipid-mediated gene transfer through intravenous administration are the cationic lipid structure, the charge ratio (+/−) between the cationic vector and DNA, [14] [15] [16] slightly positive PEI complexes as compared with DNA alone, whereas cationic lipid-based vectors, DOTAP and GL-67A, gave not significant luciferase activity. Both types of polyplexes gave similar levels of lung luciferase expression by targeting different airway cell populations. PEI 25K complexes determined high levels of GFP in the bronchial cells, confirming confocal data on fluorescent complexes internalization. PEI 22K complexes gave mainly high GFP signal in the distal tract of the bronchial tree, where tagged complexes were recovered. Fluorescent lipid complexes were found in aggregates in the lumen of bronchi totally (DOTAP) or partially (GL-67A) co-localizing with surfactant protein A. Results indicated that cationic polymers could overcome the surfactant barrier which inhibited airway cell transfection mediated by cationic lipids. Gene Therapy (2000) 7, 1753-1760.
size of liposomes. 11 Charge ratio between cationic polymers (ie PEI) and DNA has also been shown to be determinant in obtaining efficient lung transfection. 12 A formulation suitable for intravenous injection may not work when administered in trachea. Few studies have addressed this hypothesis and showed that in case of liposome DODAC/DOPE the same ratio of lipid to DNA was optimal for both intravenous and intratracheal administrations. 7 On the other hand, neutral complexes formed between linear PEI and DNA gave higher levels than positive complexes when injected in the trachea of newborn rabbits. 6 The observation that tracheal insufflation of plasmid DNA resulted in transfection of rat lungs to the same extent as injection of plasmid-cationic liposome complex 17 has thus brought us to investigate the role of surfactant in cationic lipid-mediated gene transfer to the lungs. In vitro studies have demonstrated that natural and synthetic preparations of surfactant markedly inhibited gene transfer mediated by cationic liposome, 18 but not by PEI and dendrimers. 19 However, the role of surfactant has not been studied in vivo.
While previous studies have addressed the physicochemical properties of lipoplexes and polyplexes, the tissue factors that regulate the transfection efficiency of nonviral vectors are still largely unknown. Indeed, the efficacy of gene therapy would also depend on the cells targeted by the nonviral vectors. The respiratory cell type to be transfected could be different in diseases which involve either bronchial/bronchiolar cells, such as CF, 2 or the alveolar cells, like neonatal respiratory distress syndrome. 20 We have thus undertaken this study to explore the biodistribution of cationic vector/DNA complexes in the lungs and the cell types which are targeted directly comparing two ways of administration: intravenous and intratracheal.
Our results show that the same cationic vector/DNA complexes behaved differently depending on the route of administration. Following a single intravenous injection, the main constraint to gene transfer was represented by the affinity of the complexes for the plasma membrane of endothelial cells, while for the intratracheal delivery the interaction with the surfactant played a major role. Moreover, immunohistochemistry studies revealed that the cationic vectors had different cellular targets when administered through the trachea.
Results
Luciferase expression in the lungs Transfection efficiency of gene delivery to the airway epithelium was studied comparing two different classes of cationic vectors after systemic (intravenous) or local (intratracheal) administration. We have previously shown that a single injection of DNA complexed to the cationic polymer polyethylenimine (PEI) 22K into the tail vein of adult mice efficiently transfected primarily the lung and, to a lesser extent, heart, spleen, kidney, and liver. 13 As shown in Figure 1a , the other vectors seemed to mediate lower levels of luciferase expression in the lungs, with DOTAP Ͼ PEI 25K Ͼ GL-67A. The most positive complexes gave the highest luciferase levels in the lungs and the maximal activity was obtained with PEI 22K at 15 equivalents of amino-to-phosphate (N/P) groups (corresponding to 2.4 +/− charge ratio). No luciferase expression was obtained with DNA alone or with complexes containing a control plasmid coding for ␤-galactosidase. Statistical analysis revealed that PEI 22K (15 N/P) and DOTAP (3.6 and 4.8 N/P) mediated luciferase levels which were significantly higher than those achieved by DNA alone. No significant difference in luciferase expression was observed with PEI 25K/DNA or GL-67A/DNA complexes versus DNA alone for all N/P equivalents.
In the case of intratracheal injections, the same complexes behaved in a different manner. The cationic lipid DOTAP mediated from low to undetectable levels of expression with the most positive complexes (4.8 N/P equivalents, 4.8 +/− charge ratio) (Figure 1b) . The other cationic lipid-based vector GL-67A seemed to give higher levels of lung luciferase than DOTAP with the less positive complexes (0.25-0.5 N/P, corresponding to 0.75-1.5 +/− charge ratio), but nevertheless showed a decrease as DOTAP as the amount of the vectorial component increased. PEI-mediated transfection determined significantly higher levels and maximal luciferase activity with slightly positive complexes (5-10 N/P equivalents, 0.8-1.7 +/− charge ratios) ( Figure 1b ). Lung luciferase levels in mice transfected with PEI 22K and PEI 25K were the highest and the most reproducible in all the animals. Uncomplexed DNA gave detectable expression only in four mice out of eight, indicating a poor reproducibility in lung transfection. Statistical analysis showed that PEI 22K (10 N/P) determined significant higher luciferase levels than uncomplexed DNA. When the conventional cut-off of 10 2 RLU/mg protein was considered, also PEI 25K (5 N/P) resulted in significantly higher luciferase expression than DNA alone. On the contrary, both cationic lipid-based vectors DOTAP and GL-67A did not reach significance versus DNA alone with all the N/P ratios, although in the case of GL-67A (0.25 N/P) the mean luciferase level was similar to that of PEI 22K (10 N/P).
These results showed that the same complexes transfected the lungs with different efficiency when injected intravenously or in the trachea, suggesting that different barriers to gene transfer are involved in the two routes of administration.
Biodistribution of the complexes
Cationic vector/DNA complexes were fluorescently tagged by inclusion of 0.4 N/P equivalents of FITC-poly-L-lysine (pLys) to follow their biodistribution after injection. The transfection efficiency of labeled complexes was not affected either in vitro or in vivo (data not shown). In order to assure the co-localization between FITC-pLys and DNA, the plasmid was covalently labeled by incorporating dUTP-Texas Red with a nick translation system. A549 cells were incubated with double labeled complexes and the transfection was stopped at 1 h of incubation. The signal corresponding to both Texas Redplasmid DNA and FITC-pLys was observed in the cells and co-localized completely either in DOTAP (Figure 2a and b) or PEI 22K complexes (Figure 2d and e). These results showed that the FITC-pLys was present in the complexes as long as 1 h after the transfection.
FITC-labeled complexes were injected in the tail vein of the C57Bl/6 mice, the animals were killed after 1, 10 and 30 min from the injection, the lungs were cryosectioned and observed at confocal microscopy. After 10 min, the FITC-complexes were evenly distributed in the alveolar region either with DOTAP/DNA (3.6 N/P) ( Figure 3a 
Figure 2 Confocal microscopy of A549 cells transfected with doubly-labeled complexes. A549 cells were transfected for 1 h with doubly-labeled DOTAP (a-c) or PEI (d-f) complexes containing FITC-pLys (a and d) and Texas-Red labeled DNA (b and e). Transmission images of cells with superimposed FITC-pLys fluorescence are shown in (c) and (f). Co-localization between

Localization of transgene expressing cells
Transgene expression in mouse lung was detected performing immunohistochemistry with an antibody directed against green fluorescent protein (GFP). Intravenous injections of GFP-coding plasmid complexed with PEI 22K gave positive signal in the alveolar region comprising endothelial cells and pneumocytes (Figure 5a ), confirming the previous observations with ␤-galactosidase transgene. 13 After an intratracheal injection, different cell targets were obtained with PEI 25K, PEI 22K, and GL-67A. PEI 25K complexes determined GFP positivity in bronchial cells (Figure 5c ), with lower signal in the alveolar region (not shown). In contrast, PEI 22K complexes gave mainly high GFP signal in the distal tract of the bronchial tree (alveolar ducts) (Figure 5d ), whereas few positive airway cells in the bronchi were detected. GL-67A transfection resulted in equally distributed few single GFP-positive cells both at the bronchial and respiratory bronchiolar level (Figure 5e ). No GFP-expressing cells were detected after the intratracheal administration of DOTAP complexes (not shown).
Discussion
Intravenous and intratracheal delivery of DNA complexes have been envisioned as two strategies to obtain gene transfer to the lungs. A direct comparison between these two routes of administration was assessed considering lipid and polymeric classes of nonviral vectors. Data showed that complexes with the same charge ratio behaved differently according to the route of administration. In the systemic delivery, the more positive the complexes the higher the lung luciferase levels. The requirement of high +/− charge ratio for efficient intravenous gene transfer has also been demonstrated for other cationic vectors such as DOTMA/DOPE and DOLCE/DOPE 21 and LPD (lipid-protamine-DNA). 16 It is possible that the excess amount of positive charges required for an optimal transfection through this route is essential in neutralizing negatively charged blood components, that otherwise could inhibit the activity of the DNA/cationic vector complexes at low charge ratio. 14, 22 Moreover, the role of cationic vectors is thought to protect plasmid DNA from DNase degradation in the presence of serum. 13, 23 Indeed, naked DNA gave negligible gene expression when administered intravenously, as shown by us in this report and by others. 17, 21 The efficiency of gene expression differed greatly among the vectors we have tested (Ref. 13 and data shown herein). Chemical structure of the vectors and cationic vector/DNA ratio might determine different sizes of complexes that could be relevant for an efficient gene transfer through intravenous administration. The size of the DOTAP/DNA complexes was shown to be 181-280 nm, GL-67A complexes were 400-600 nm (SH Cheng, personal communication), while 60-80 nm were obtained for PEI 25K and 22K complexes. 24, 25 The effect of particle size determined five-fold higher levels of expression for complexes prepared using 400-or 800-nm extruded liposomes as compared with those prepared using 100-nm extruded liposomes. 21 As shown for MLV and LUV/DNA complexes, 7 lipid complexes might become trapped in capillaries of lung when injected intravenously, due to their large size. On the other hand, highly compacted PEI/DNA complexes might circulate faster than lipoplexes and consequently the contact time between polyplexes and cell surface may be reduced resulting in decreased transfection efficiency. Our data on the biodistribution in the lungs of the different types of complexes demonstrated that factors other than size might have significant importance. In fact, polyplexes which ranged in the same size were differently deposited in the lung 10 min after the administration: PEI 22K complexes were evenly distributed, whereas no labeled PEI 25K/DNA complexes were detected justifying different levels of expression. Moreover, the large GL-67A complexes were not retained in the lungs, as shown by the absence of fluorescence at 10 min. Overall, these data suggest that high affinity of complexes for the endothelial luminal plasma membrane may be essential for an efficient lung gene transfer through the systemic route.
After an intravenous injection, cationic vector/DNA a b c d e f complexes gave GFP expression in the alveolar region, confirming our previous results with X-gal staining for ␤-galactosidase. 13 Although DOTAP and PEI 22K labeled complexes were biodistributed in a similar fashion, the transgene levels in the lungs were higher for PEI 22K. It may be possible that highly compacted PEI 22K complexes favorably cross the endothelium, as was shown for pulmonary endothelium in mice 26 and endothelial glomerular barrier in the rat kidney. 25 Moreover, greater diffusibility of these complexes related to their small size and stability was also demonstrated in the mouse central nervous system. 27 Transfection through intratracheal administration involved different factors for successful gene delivery into the lungs as demonstrated by injecting the same DNA complexes used for systemic administration. The highest levels of transfection were obtained using PEIs with low ratio of positive charges. As opposed to systemic delivery, intratracheal-injected complexes do not have to interact with the negatively charged blood components. Thus, less positive complexes are needed for high levels of lung transfection, as in the case of intraventricular injection in the mouse central nervous system. 27 Confocal microscopy studies revealed that lipoplexes, but not polyplexes, aggregated in the lumen of bronchi and co-localized either totally (DOTAP) or partially (GL-67A) with the surfactant protein A. GL-67A was chosen since it was shown to be a more efficient lipid formulation than Gene Therapy other commercial lipids, such as DOTAP, for mouse and human lung transfection. 9, 28 It includes a neutral lipid, DOPE, and a polyethylene glycol-containing lipid, DMPE-PEG5000, which stabilizes the bilayer configuration. It could be possible that these adjunctive components might have influenced the interaction with surfactant. These data confirm for the first time in vivo, the previous in vitro findings of the inhibition of cationic lipid-mediated gene transfer by natural and synthetic surfactant preparations. 18, 19 The lack of inhibition by surfactant of cationic polymer-mediated gene transfer is similar to what has been seen using adenoviral vectors. Indeed, it has been shown that surfactant facilitates adenovirally mediated gene transfer in the peripheral lung and enhances transgene expression. 29 Both types of polyplexes gave similar levels of lung luciferase expression by targeting different airway populations. PEI 25K gave high levels of GFP in the bronchi, confirming confocal data on complex internalization by this pulmonary area, while GFP expression and FITC signal were correspondingly low in the alveoli. PEI 22K complexes were found on the apical surface of bronchial cells and gave low levels of GFP in the bronchi, whereas more polyplexes and corresponding GFP expression were revealed in the distal tract of the broncho-alveolar tree. Therefore, PEI 22K and 25K complexes could be useful for obtaining therapeutic gene transfer in different lung diseases, depending on the cellular population to be targeted. 30, 31 GL-67A transfection resulted in a low GFP expression in both the bronchial and the distal pulmonary districts. This distribution may reflect some complexes which escaped the surfactant barrier. However, the degree of cellular correction in the CF epithelium is in the order of 5%, 32 indicating that GL-67A could be of therapeutic relevance in this disease.
Figure 5 Immunohistochemical detection of GFP transgene expressing cells. Intravenous injection: a positive signal in alveoli of mice injected with PEI 22K complexes (a). Intratracheal injection: bronchial epithelial positive cells in mice injected with PEI 25K complexes (c) and distal tract of bronchoalveolar tree injected with PEI 22K complexes (d). Single bronchial epithelial cells and respiratory bronchiolar cells (e) in mice injected
A number of studies have demonstrated that intratracheal administration of naked DNA results in equal or better in vivo gene transfer to the airway as compared with the administration of plasmid-cationic liposome complexes in the mouse, 33 rat, 17 and man. 34 Our data show that intratracheal injection of DNA resulted in gene expression in mouse airways in the absence of any enhancing agent; however, naked DNA gave positive lung transfection in half of the treated mice, demonstrating low reproducibility in gene transfer. On the other hand, DNA/cationic polymer complexes gave high, significant and reproducible lung transfection and therefore constitute a better choice for directly targeting the airways than does naked DNA.
In summary, our results suggest that the interaction of complexes with plasma membrane of endothelial cells (likely due to affinity for a cellular receptor) could play a relevant role in the efficiency of cationic vectormediated gene delivery to the lungs after systemic administration. Moreover, the intratracheal injections show that polyplexes could overcome the surfactant barrier which inhibit lung transfection by cationic lipids. These data would indicate that polyplexes, and in particular PEI 25K, might be more suitable vectors among those used so far in preclinical and clinical studies for a gene therapy approach to lung monogenic diseases, like CF, in which bronchial cells must be targeted. 2 
Materials and methods
Plasmids
Plasmid pCLuc carrying Photinus pyralis luciferase coding region under the control of the cytomegalovirus (CMV) immediate-early enhancer/promoter region was a kind gift of Lucia Monaco (HS Raffaele, Milano, Italy). pE-GFP-C3 carrying the coding region for an enhanced version of Aequorea victoria GFP was purchased from Clontech (Palo Alto, CA, USA). Plasmid DNA was purified by the double CsCl-ethidium bromide gradient centrifugation method. 35 Purity of the plasmids was determined by absorbance at 260 and 280 nm and by 1% agarose gel electrophoresis.
Labeled DNA was prepared by incorporating dUTPTexas Red (ChromaTide Texas Red-12-dUTP, Molecular Probe, Eugene, OR, USA). Fluorescent nucleotides were covalently linked using the Nick Translation System (Gibco-BRL, Life Technologies, San Giuliano, Milan, Italy). Separation between labeled DNA from non-incorporated nucleotides was performed with Sephadex G-50 Fine column (Amersham Pharmacia Biotech, Uppsala, Sweden).
Preparation of cationic vector/DNA complexes
The complex formation of DNA with linear PEI 22K (Exgen 500, Euromedex, Souffelweyersheim, France), branched PEI 25K (Sigma-Aldrich, St Louis, MO, USA), and DOTAP (Roche Molecular Biochemicals, Mannheim, Germany) was carried out as previously described. 13 GL-67/DOPE/DMPE/PEG5000 (GL-67A; kindly provided by SH Cheng, Genzyme, Framingham, MA, USA) was formulated at 1:2:0.05 molar ratio 9 and reconstituted as 2 mm aqueous solution. From 0.25 to 4 N/P equivalents of GL-67A per DNA phosphate were used, that is from 0.75 to 12 l per 2 g DNA. 16 .1 kDa FITC-conjugated polyl-lysine hydrobromide (FITC-pLys) (Sigma-Aldrich) was prepared as 1 mm stock solution in water. Labeled complexes containing FITC-pLys were prepared by pre-incubation of 2.7 l of 1 mm FITC-pLys per microgram DNA, corresponding to 0.4 N/P equivalents, for 15 min at room temperature, followed by addition of cationic vectors.
In vitro transfections A549 (human type II pneumocytes) cell line was from ATCC and was cultured in DMEM/HAMF12 (1/1), 10% fetal calf serum (Hyclone, Logan, UT, USA), 2 mm l-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin (Gibco BRL). Cells were seeded in 24-well plates on to glass coverslips at 50% confluence. One hour after transfection with fluoresceinated complexes, cells were fixed in 4% paraformaldehyde in PBS for 10 min at room temperature and mounted with aqueous mounting media (Electron Microscopy Science, Washington, PA, USA). Samples were analyzed with a confocal microscope (BioRad MRC 1024; Hercules, CA, USA) equipped with an argon-krypton laser.
In vivo transfections
C57Bl/6 mice of 4-6 weeks of age were injected either through the tail vein or in the trachea with cationic vector/DNA complexes in 5% w/v glucose. 50 g of pCLuc and 75 g of p-EGFP-C3 were complexed with the vector in a range of 400-700 l for the tail vein and in a range of 300-650 l for the intratracheal injection. Plasmid DNA or DNA/vectors complexes were delivered to the airways by either direct intratracheal injection or using a 24G catheter (Terumo, Leuven, Belgium). No difference of luciferase expression was observed between the two procedures. In both cases the trachea was exposed with a local incision, slowly injected and the incision was then sutured. Twenty-four hours after injection, mice were killed and the lungs were removed and assayed for luciferase or GFP expression.
Evaluation of transgene expression
Quantification of luciferase activity in the mice lungs has already been described. 13 Briefly, transfected lungs were homogenized on ice in 2 ml of lysis buffer (25 mm Tris/HCl, 2 mm DTT, 2 mm EGTA, 10% glycerol, 1% Triton X-100, pH 8.0) and centrifuged at 15 800 g for 10 min at 4°C. Seventy microliters of the supernatant was analyzed for luciferase activity and in parallel, purified luciferase (Roche), dissolved in the lung homogenates of nontreated animals, was used as a standard. In these conditions, a conversion factor of 15 160 relative light units (RLU)/pg luciferase was obtained for the lungs.
GFP expression was evaluated on cryosections by immunohistochemistry with an anti-GFP polyclonal antibody (Molecular Probes) and using the avidin-biotin-peroxidase detection system (ABC Vectastain Elite kit, Vector Laboratories, Burlingame, CA, USA). Incubation of cryosections with primary antibody (1:800) was carried out in PBS/1% BSA/2% normal goat serum for 1 h at room temperature. After extensive washing, lung cryosections were incubated with biotinylated secondary antibody (1:400) (anti-rabbit IgG H+L, from Vector Laboratories). Slides were counterstained with Harris Hematoxylin (Sigma-Aldrich). Immunohistochemistry was performed on lung sections taken randomly from all the lobes of three animals per group and showed a similar transgene distribution.
Biodistribution of labeled complexes
C57Bl/6 mice transfected with fluoresceinated complexes were killed after 1-30 min. Lungs were fixed in 4% paraformaldehyde in PBS at 4°C, cryoprotected in 10% sucrose in PBS at 4°C and frozen in liquid nitrogen. Organs were included in OCT (Miles, Elkhart, IN, USA), cryosectioned in 5-m thick sections, coverslipped with aqueous mounting media, and analyzed with a confocal microscope.
Immunofluorescence staining
Lung cryosectioned slides were stained using a rabbit polyclonal antibody raised against human surfactant protein-A (kindly provided by John Alcorn, Southwestern Medical Center, Dallas, TX, USA) for 30 min at 37°C in PBS 1% BSA. Sections were incubated with TRITC-conjugated secondary antibody for 30 min at 37°C, mounted with aqueous mounting media, and analyzed at confocal microscope.
Statistical analysis
As the variables did not show a Gaussian distribution, non-parametric tests were used. The comparisons of cationic vectors/DNA at all N/P equivalent and DNA alone were performed by using Kruskal-Wallis analysis and for post hoc comparisons the Dunn procedure was used. A cut-off of 10 2 RLU/mg protein for luciferase expression was used to compare the proportion of positive mice between cationic vectors/DNA N/P equivalents and DNA alone by means of the Chi-square test. SAS Statistical Package was used for statistical analysis. 36 
